New cell therapy KITE-197 shows promise for tough lymphoma cases
NCT ID NCT06079164
First seen Jan 08, 2026 · Last updated May 22, 2026 · Updated 23 times
Summary
This early-phase study tests a new treatment called KITE-197 for people with large B-cell lymphoma that has come back or not responded to other therapies. The study has two parts: first, to find a safe dose, and second, to see how well that dose works. About 39 participants will receive a single infusion of their own immune cells that have been modified to attack the cancer. The main goals are safety and whether the cancer disappears completely.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RELAPSED/REFRACTORY LARGE B CELL LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cross Cancer Institute
Edmonton, T6G 1Z2, Canada
-
Henry-Joyce Cancer Clinic
Nashville, Tennessee, 37232, United States
-
Jewish General Hospital
Montreal, H3T 1E2, Canada
-
QEII Health Sciences Centre
Halifax, B3H 2Y9, Canada
-
Royal Brisbane and Women's Hospital
South Brisbane, Queensland, 4101, Australia
-
Royal Prince Alfred Hospital
Camperdown, New South Wales, 2050, Australia
-
St. David's South Austin Medical Center
Austin, Texas, 78704, United States
-
Swedish Cancer Institute
Seattle, Washington, 98104, United States
-
Sylvester Comprehensive Cancer Center
Miami, Florida, 33136, United States
-
The Alfred Hospital
Melbourne, Victoria, 3004, Australia
-
University of Chicago Medical Center
Chicago, Illinois, 60637, United States
Conditions
Explore the condition pages connected to this study.